A nasopharyngeal antigenic test «made in France»

detection of SARS-CoV-2 (Covid19)

DTF medical & Biospeedia provide healthcare professionals,

companies and communities a nasopharyngeal antigenic test «made in France»

Designed and developed by Biospeedia, a spin-off of the Institut Pasteur based on the Santé Innovations campus of Saint-Etienne Métropole, produced on the Lyon site of the Delpharm group, a major player in pharmaceutical subcontracting, This test is distributed by the Stéphanoise company DTF medical, specialist in the distribution of medical devices. A partnership that allows the French health system to have a nasopharyngeal antigenic test «made in France».

Beyond the similarity with PCR tests, antigen tests for the detection of SARS-CoV-2 (Covid19) are cheaper and faster, offering a result in less than 15 minutes. Available from November, the monthly production capacity of these tests will increase to reach 1.5 million products by January 2021, with a minimum of double if needed.

A fast and reliable diagnostic test

This immunochromatographic test is designed for the qualitative detection of the specific antigen of SARS-CoV-2 (Covid19) in a human nasopharyngeal swab sample. It is intended for use by professionals as a screening test and as an aid in the early diagnosis of active SARS-CoV-2 infection. Antigen tests detect proteins specific to the surface of the virus and deliver a result in 5 to 15 minutes. Practical to use, they do not require additional equipment and can be made in city medicine. Eligible for the conditions of support, this test is listed by the Ministry of Health.

A partnership at the heart of Santé’s Stéphanois ecosystem

For nearly 70 years, DTF medical has been supporting Life. In addition to its activities in the areas of aerosol therapy (Atomisor®) and breastfeeding (Kitett®), always driven by a constant search for innovation, DTF medical teams support BioSpeedia, in support of government action in its strategy of “Test – Alert – Protect”.

BioSpeedia, a spin-off of the Institut Pasteur, founded in 2011, specializes in rapid testing of various infectious diseases. Based on the Santé Innovations campus of Saint-Etienne Métropole, it enjoys privileged access to the Saint-Etienne University Hospital, the GIMAP (Group on Mucosal Immunity and Pathogenic Agents) Jean Monnet University and the Ecole des Mines and a license from the Institut Pasteur giving access to major reagents. These resources & skills have enabled the development of diagnostic tests in the fight against Covid19.